Anti-MESO CAR-T cell(Ruijin Hospital)

N/A

Report date: 2025/07/03 20:00:09

Base Information

Drug NameAnti-MESO CAR-T cell(Ruijin Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-Mesothelin

TargetsMesothelin

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesShanghai Rui Jin Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Rui Jin Hospital

Active IndicationsN/A

Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A